Official name
Response Plus Holding PJSC
ADX · RPM
Response Plus Holding PJSC
- Research depth
- Detailed review in preparation
- Sector lens
- Healthcare
- Reporting context
- FY2025 signed audited summary; H1 2025 reviewed IAS 34; H1 2026 missing as of 2026-08-11
Company overview
- Exchange
- ADX
- Ticker
- RPM
- ISIN
- AER001001018
- Market identifier code (MIC)
- XADS
- Stable research ID
- ADX-RPM
- Industry evidence
- Pre-hospital emergency medical services, occupational health, onsite clinics, medical staffing and training
- Sector
- Healthcare
- Instrument type
- Listed equity
- Research status
- Detailed review in preparation
- Latest financial period
- FY2025 signed audited summary; H1 2025 reviewed IAS 34; H1 2026 missing as of 2026-08-11
- Identity evidence checked
- 2026-08-11
- Identity checked
- Identity revalidation is due; this dated record is not proof of current listing status
- Listing lifecycle
- Primary active route confirmedA dated identity record does not prove the current listing state after its verification date.
Issuer participationProfile foundation available
Response Plus Holding PJSC · What the issuer can provide
- business and research review
- current identity confirmation
Why this company is in the directory
Coverage follows a reconciled listed-security identity and dated evidence. Inclusion describes research scope only; it is not a ranking, recommendation or claim of complete financial coverage.
- Identity reconciliation
- Official exchange route verified before public inclusion
- Current public research layer
- Company profile published · detailed review in preparation
- Evidence boundary
- Identity record checked: 2026-08-11
Company evidence map
Open a card to inspect its public evidence. Missing, stale, conflicting or unavailable data is never replaced with an estimate.
Identity-only public coverage; no completed research review is claimed.Stale
Open the Company BriefListed-security identity
Revalidation is due; the dated record is not proof of current listing status.
Checked: 2026-08-11→AvailableIssuer profile
Verified public issuer fields are available.
→AvailableSource documents
3 source documents are linked to public facts.
→MissingCompany activity
No linked activity currently passes every public source-document check.
→AvailableOfficial sources
A rights-reviewed official identity source is linked.
→Public identity dossier
Verified listing identity
The fields below come from the current public company registry and any human-published issuer profile. Empty issuer-contact fields stay visibly missing until source and publication-rights review are complete.
- Official listed name
- Response Plus Holding PJSC Available
- Exchange
- ADX Available
- MIC
- XADS Available
- Ticker
- RPM Available
- ISIN
- AER001001018 Available
- Instrument
- Listed equity Available
- Sector
- Healthcare Available
- Industry
- Pre-hospital emergency medical services, occupational health, onsite clinics, medical staffing and training Available
- Identity checked
- 2026-08-11 Available
- Official website
- Missing Missing
- Investor relations
- Missing Missing
- Registered address
- Missing Missing
- Public contacts
- Missing Missing
Company activity context
Only exact-security, human-published activity that passes every public source-document check can appear here.
No linked update currently passes every public gate.
Open the full chronologyPublic identity passport
Required identity fields are shown individually with their evidence state. A public link is not reuse permission, and a blank is never converted to a guess.
Ticker
RPM
Exchange and MIC
ADX · XADS
ISIN
AER001001018
Instrument type
Listed equity
Sector and industry
Healthcare · Pre-hospital emergency medical services, occupational health, onsite clinics, medical staffing and training
Listing status
Primary active route confirmed
Official website
Not available in the public evidence layer
Investor relations
Not available in the public evidence layer
Registered address
Not available in the public evidence layer
Public email
Not available in the public evidence layer
Public phone
Not available in the public evidence layer
Business description
Not available in the public evidence layer
Verified issuer profile
A verified public issuer profile has not been published yet.
Business model
B2B/B2G medical contract-services platform that deploys clinicians, paramedics, ambulances and onsite clinics for industrial sites, infrastructure, airports and events; provides occupational health, medical manpower, emergency/event cover, training/consulting and emerging evacuation services. Economics depend on contract pricing/renewal, billable staff and fleet utilisation, staff-cost inflation, mobilisation, clinical quality, receivable/unbilled collection, capex and acquired Prometheus integration.
Response Plus: the ambulance count moved and the profit fell while revenue rose
Two official fleet counters that do not agree with each other
The issuer's About pages said more than 350 ambulances and more than 420 onsite facilities when the research file was compiled on 12 August 2026; the same pages read on 25 August 2026 say more than 500 ambulances and more than 501 facilities. Nothing in the audited statements arbitrates between them: the fleet is never counted there. The Hajj 2026 mobilisation of over 6,000 paramedics and over 300 ambulances is a third figure of a different kind: peak event capacity hired for a season, not a standing asset base. For a company whose product is people and vehicles arriving on time, the lack of an audited count is the central measurement gap.
Growth that the payroll ate
FY2025 revenue rose 13.43% to AED 516.055m and profit fell 6.59% to AED 49.956m. Staff cost went to AED 331.963m, 64.33% of revenue against 59.99% a year earlier, and materials and outsourced services took another 9.44%. Over five years revenue grew 72.2%, from AED 299.608m in FY2021, while profit shrank 23.2% from AED 65.009m. Contract revenue supplied AED 356.690m of FY2025, medical services AED 111.490m, training and consultancy AED 35.105m and medical goods AED 12.770m. The medical and occupational business earned AED 51.711m of profit before tax on AED 471.223m; training and consulting earned AED 2.499m on AED 44.832m, so the acquired activity carries the thinner margin.
A depreciation decision worth AED 1.933m
The useful life of motor vehicles was extended from five years to seven. Without that estimate change FY2025 depreciation would have been AED 1.933m higher. It is disclosed and legitimate, but it lands in a year when profit fell anyway, so the underlying operating decline is slightly larger than the reported one. No cash moved.
Money owed, money pledged and money already spent
Gross trade receivables were AED 146.314m against AED 24.904m of expected credit loss, a 17.02% allowance, with AED 21.083m over 360 days fully provided and a further AED 46.408m unbilled. The five largest customers held about 39% of outstanding receivables, down from 60%, 41% and 59% in the three prior years, but that is credit concentration and says nothing about which customers produce the revenue. Cash was AED 24.872m against AED 42.767m of borrowings and AED 4.822m of leases, so net debt was AED 17.895m, or AED 22.717m with leases; the AED 35m term facility is secured by assignment of receivables, share pledges and subsidiary guarantees, and letters of guarantee were AED 50.769m. Operating cash flow of AED 58.550m covered AED 33.32m of vehicle and equipment purchases.
The half-year that grew fastest is the one with no cash flow statement
Management reported H1 2026 revenue and other income of AED 390.42m against AED 248.06m, gross profit of AED 115.01m against AED 65.73m and profit of AED 39.84m against AED 20.32m. Assets rose to AED 545.11m from AED 387.22m, and current liabilities more than doubled to AED 205.88m from AED 93.46m, attributed to trade payables and short-term borrowings. There is no reviewed interim package and no statutory cash-flow statement behind those numbers, so the acceleration cannot be described as cash-backed. Prometheus, consolidated since 24 April 2024, cost AED 57.664m and produced AED 12.722m of customer-contract intangibles amortised over seven years.
What Response Plus does not put in writing
Contract duration, renewal rates, termination rights and remaining performance obligations are absent, as is any named customer revenue concentration; signed contract values of AED 117m in the UAE and SAR 36m in Saudi Arabia are announcements, not revenue. Billable workforce, ambulance and clinic utilisation are not published at all, which is why the fleet dispute above cannot be settled. Covenant headroom on the secured facility is undisclosed. Dr Shamsheer Vayalil holds 54% and Alpha Dhabi Health Holding 36%, and the founder shareholder account was repaid AED 8m during the year. Of the five-member board only two are classified independent, the controlling shareholder chairs the nomination and remuneration committee, and the audit committee chair is not among the independents. The FY2024 final dividend of AED 20m and the FY2025 interim of AED 18m were paid; the general meeting then approved no final dividend for FY2025.
The old summary table is temporarily withheld because its display did not preserve the exact relationship between metrics, periods and labels. This is a limitation of the website table, not a claim that the issuer did not disclose the data. The review text and sources are preserved. Review documents and sources.
Key reported figures
Physical assets
- issuer site as read on 25 August 2026: more than 500 ambulances, more than 501 onsite clinics and facilities, more than 3,000 medical professionals
- the same pages recorded in the research file on 12 August 2026: more than 350 ambulances and more than 420 facilities and clinics
- more than 650 events covered a year and more than 1,000 helicopter medical transfers a year
- Hajj 2026 mobilisation in Saudi Arabia: more than 6,000 paramedics and more than 300 ambulances, an event peak rather than a standing fleet
- operations described across nine markets: the UAE, Saudi Arabia, Oman, Jordan, India, the United Kingdom, Switzerland, Norway and the Bahamas
- FY2025 activity reported by management: 626 events and around 425 staff mobilised, UAE contracts signed for AED 117m and Saudi contracts for SAR 36m
- unbilled receivables of AED 46.408m alongside AED 121.410m of net trade receivables
Group entities
- Prometheus Medical International - acquired 24 April 2024 for AED 57.664m, of which AED 47.743m paid and AED 9.921m payable; net cash outflow AED 46.753m
- ICATT Response Plus - long-range air ambulance and commercial-flight medical escort
- Dr Shamsheer Vayalil - 108m shares, 54%
- Alpha Dhabi Health Holding - 72m shares, 36%; the remaining 10% is not evidenced as executable float
Geographic footprint
- United Arab Emirates - AED 418.06m, 81.01% of FY2025 revenue
- Saudi Arabia - AED 81.83m, 15.86%
- other markets - AED 16.17m, 3.13%
How to read this company's economics
Numerical values remain in the separate source-document checkHow the operating model becomes revenue and cash
Healthcare economics run through patient volumes, case or product mix, capacity, payer terms and clinical or manufacturing delivery. Hospitals, pharmacies and drug manufacturing have different recognition and working-capital cycles.
Five questions before reading the headline
1. What created demand?
Separate patient, prescription, product and capacity demand by geography and payer.
2. What was actually delivered?
Tie visits, beds, procedures or units to delivered and billable service.
3. What determines the margin?
Read clinical or product mix, staffing, procurement and utilisation before margin.
4. Where is cash tied up?
Trace insurer receivables, inventory, payables and provisions to cash conversion.
5. What must be funded next?
Match facilities, equipment and manufacturing capex to licensed capacity and demand.
Official-source snapshot
What the company does and where to verify it
A manually reviewed, paraphrased snapshot from issuer and official market records. Each field keeps its exact source and verification date.
No public snapshot has passed this separate review yet.
Official website, investor-relations, market-record and public contact fields remain unavailable here until their exact source, current value and reuse boundary are reviewed. Nothing is inferred from aggregators or another company.
Healthcare provider analytical model
The metrics below define the correct analytical lens for this business model. They contain no company values: a value appears only after official-document provenance and editorial verification.
- Licensed and operational beds
- Licensed, installed and operational beds kept separate by facility and reporting date.
- Bed occupancy
- Occupied bed-days relative to available bed-days for the same hospital perimeter and period.
- Patient volume
- Inpatient admissions, outpatient visits and procedures kept as separate counts.
- Revenue per patient
- Revenue per visit, admission or procedure with payer, service and period basis stated.
- Payer mix
- Revenue or patient share by insurer, government, self-pay and other disclosed payer classes.
What changed
Full company chronologyVerified company activity
Only exact-security activity that passes the automatic source, locator, date and localization gates is shown. Exceptions remain unpublished. Each date keeps its lifecycle meaning.
No linked activity currently passes every public source-document check.
Sources
Identity evidence
- Identity evidence
- Exchange-hosted evidence
- Identity record checked
- 2026-08-11
- Evidence host
- www.adx.ae
Research collections
This company appears in the dated public collections below. Membership describes coverage and evidence context; it is not a ranking or recommendation.
ADX companies
Public profiles with canonical exchange ADX.
- Membership version
- v1
- Effective from
Healthcare
Public profiles assigned to this sector in the dated public registry.
- Membership version
- v1
- Effective from
Full public company reviews
Public profiles with a complete source-linked review currently visible to every reader.
- Membership version
- v1
- Effective from
Identity revalidation due
Dated public identity checks earlier than 18 August 2026; this does not assert current listing status.
- Membership version
- v1
- Effective from
Dubaist · Free / Premium
Research products
Open this company's free source-linked fundamental-review preview or compare coverage packs and ongoing monitoring. Coverage is not an investment ranking.
More companies in this sector
Explore factual peers using the same sector lens. Order is directory-based, not a ranking or recommendation.
PureHealth Holding
Vertically integrated Care and Cover platform. Care includes UAE hospital/clinic networks, UK Circle Health, Greece/Cyprus HHG, laboratories, pharmacies, medical procurement/logistics and clinical IT. Cover includes Daman health insurance and emerging P&C. Economics depend on patient volumes, occupancy, acuity/case mix, tariffs and payer collection, insurance pricing/claims/reserves/solvency, procurement mandates, physician capacity, M&A integration and lease/put-option obligations.
- Licensed and operational beds
- Bed occupancy
- Patient volume
Burjeel Holdings
Hospitals, medical centres, pharmacies and specialized complex-care services across the GCC.
- Licensed and operational beds
- Bed occupancy
- Patient volume
Gulf Pharmaceutical Industries
Regional pharmaceutical group developing, manufacturing and commercialising generic medicines and selected biologics across MENA and Africa. Economics depend on product registrations and launches, volume and facility utilisation, price/mix, gross margin, R&D productivity, quality compliance, working capital and financing.
- Licensed and operational beds
- Bed occupancy
- Patient volume